-
Glioblastoma Multiforme Treatment Market Size to Reach USD 5.68 Bn by 2033
25 Nov 2024 16:00 GMT
… (55%). Glioblastoma Multiforme Treatment Market Highlights:
North America led the glioblastoma multiforme treatment market … hemisphere glioma.
Glioblastoma Multiforme Treatment Market Regional Outlook U.S. Glioblastoma Multiforme Treatment Market …
-
Key Trend Shaping Glioblastoma Multiforme Treatment Market 2024: Innovative Therapies Transforming Treatment Landscape
15 Nov 2024 17:25 GMT
… , glioblastoma multiforme (GBM) treatment market major players, glioblastoma multiforme (GBM) treatment competitors' revenues, glioblastoma multiforme …
-
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
21 Oct 2024 12:30 GMT
… DaRT for patients with recurrent glioblastoma multiforme (“GBM”). This acceptance follows the …
-
In8bio To Present At Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
02 Dec 2024 13:06 GMT
… a Phase 2 trial in glioblastoma multiforme (GBM). Additional programs include Phase …
-
IN8bio to Present at Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference
02 Dec 2024 12:00 GMT
… a Phase 2 trial in glioblastoma multiforme (GBM). Additional programs include Phase …
-
Biopharma Takes on Deadly Brain Cancer After Decades of Failure
02 Dec 2024 05:57 GMT
… .
While considered a rare cancer, glioblastoma multiforme (GBM) is also the most …
-
Avadomide hydrochloride by Bristol-Myers Squibb for Glioblastoma Multiforme (GBM): Likelihood of Approval
09 Sep 2024 18:47 GMT
… , indolent lymphoma, hepatocellular carcinoma, primary glioblastoma multiforme, metastatic melanoma and gliosarcoma. It …
-
Olaptesed pegol by TME Pharma for Glioblastoma Multiforme (GBM): Likelihood of Approval
09 Sep 2024 08:37 GMT
… pancreatic cancer, solid tumors including glioblastoma multiforme, glioma and unspecified indication. The …
-
Ten Companies to Watch in AI Drug Discovery
29 Nov 2024 12:12 GMT
… received orphan drug designation for glioblastoma multiforme and pancreatic cancer. Another program …
-
Blocking Scar Formation Prevents Glioblastoma Recurrence
29 Nov 2024 05:32 GMT
… a macrophage-targeted therapy on glioblastoma multiforme (GBM), a common and aggressive …